Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2025-12-26 @ 2:29 PM
Study NCT ID:
NCT00827203
Status:
SUSPENDED
Last Update Posted:
2009-03-09
First Post:
2009-01-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors
Sponsor:
Synta Pharmaceuticals Corp.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
4783-11
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
David Hynds, Clinical Trials Manager
Old Organization:
Synta Pharmaceuticals